FCGR3A Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lower-Grade Glioma

Figure 6

Correlation analysis between FCGR3A expression with immune checkpoint molecules in LGG using TIMER and GEPIA databases. (a) PD1 (PDCD1); (b) PD-L1 (CD274); (c) PD-L2 (PDCD1LG2); (d) CTLA4; (e) LAG3, (f) TIM-3 (HAVCR2) from TIMER; (g)PD1 (PDCD1); (h) PD-L1 (CD274); (i) PD-L2 (PDCD1LG2); (j) CTLA4; (k) LAG3; (l) TIM-3 (HAVCR2) from GEPIA.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)